Revolution Medicines · 13 hours ago
Intern, Medicinal Chemistry
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. As an intern on the Integrated Discovery Research team, you will contribute to the discovery of new drug candidates and gain hands-on experience in synthesizing biologically active compounds.
Health CareLife ScienceMedical
Responsibilities
Being trained to synthesize biologically active compounds, including the design and execution of the synthetic routes, purification of final compounds, and participating in analog design
Planning and executing experiments to support research activities
Learning to use key instruments including LCMS, NMR, and prep HPLC
Learning to effectively present research findings to the Integrated Discovery Research team
Partnering in scientific activities with other outstanding medicinal chemists and creating an environment where all ideas are heard
Qualification
Required
Working towards bachelor's (B.S., B.A., or equivalent) degree in Chemistry or related field
Strong communication skills, well-organized, and high attention to detail
Preferred
By the start of the internship will have completed a 2 nd year organic chemistry course and the associated lab course
Preferably having basic familiarity with NMR, HPLC, and mass spectrometry from teaching labs or prior research experience
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase